Overall impact
C (49)

Commentary

Calyxt is an average overall performer. With a 'C' rating of 48.8 for overall impact (40th percentile compared to all companies), Calyxt ranks 16th out of 21 industry peers, behind Arcadia Biosciences, Envu, Rovensa and 12 others, and ahead of Nutrien, Intrepid Potash, CF Industries and 2 others. On top material causes for Calyxt's industry (Chemicals), Calyxt performs well in Child and Maternal Health (90.6 score), Child and Maternal Health (90.6), Child and Maternal Health (88.3) and 4 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (36.7 score), Child and Maternal Health (36.7), Sanitation Access (19.9) and 4 other causes where it received a 'D' or 'F' score.
Impact
Cause CLXT
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
48
Sector
Materials
Industry
Chemicals
Sub-industry
Fertilizers & Agricultural Chemicals
SASB industry
Chemicals
Headquarters
Mn, United States
Share classes
CLXT
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.
Material causes
Ethos considers the following causes material for Calyxt, based on its industry sub-industry Fertilizers & Agricultural Chemicals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.